Invest — NL says Dutch biotech gains edge by linking with high — tech sector, analysis finds

Invest-NL published a market analysis arguing the Netherlands can strengthen its biotech position by linking more tightly with high-tech industries. The report flags measurement, data analysis, automation, process development, production capacity as key constraints on scaling biotech beyond the lab. It identifies investable “enabling” technologies aligned with Dutch strengths in precision engineering, photonics, semiconductor equipment, systems integration. The analysis calls for shared national infrastructure for experimentation, measurement, process development, scale-up to shorten timelines, reduce fragmentation across startups. The deep dive launches a four-part biotech series that will map investment opportunities, scale-up barriers, solutions across agrifood, health, industrial biotech. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Invest-NL NV published the original content used to generate this news brief on Septemb